CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION

被引:896
|
作者
FREEMAN, GJ
GRIBBEN, JG
BOUSSIOTIS, VA
NG, JW
RESTIVO, VA
LOMBARD, LA
GRAY, GS
NADLER, LM
机构
[1] REPLIGEN CORP,CAMBRIDGE,MA 02139
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
关键词
D O I
10.1126/science.7694363
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although presentation of antigen to the T cell receptor is necessary for the initiation of an immune response, additional molecules expressed on antigen-presenting cells deliver essential costimulatory signals. T cell activation, in the absence of costimulation, results in T cell anergy. The B7-1 protein is a costimulator molecule that regulates interleukin-2 (IL-2) secretion by signaling through the pathway that uses CD28 and CTLA-4 (hereafter referred to as the CD28 pathway). We have cloned a counter-receptor of CD28 and CTLA-4, termed B7-2. Although only 26 percent identical to B7-1, B7-2 also costimulates IL-2 production and T cell proliferation. Unlike B7-1, B7-2 messenger RNA is constitutively expressed in unstimulated B cells. It is likely that B7-2 provides a critical early costimulatory signal determining if the T cell will contribute to an immune response or become anergic.
引用
收藏
页码:909 / 911
页数:3
相关论文
共 50 条
  • [31] The role of CTLA-4 in the regulation and initiation of T-cell responses
    Chambers, CA
    Krummel, MF
    Boitel, B
    Hurwitz, A
    Sullivan, TJ
    Fournier, S
    Cassell, D
    Brunner, M
    Allison, JP
    IMMUNOLOGICAL REVIEWS, 1996, 153 : 27 - 46
  • [32] The soluble isoform of CTLA-4 as a regulator of T-cell responses
    Ward, Frank J.
    Dahal, Lekh N.
    Wijesekera, Subadra K.
    Abdul-Jawad, Sultan K.
    Kaewarpai, Taniya
    Xu, Heping
    Vickers, Mark A.
    Barker, Robert N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (05) : 1274 - 1285
  • [33] T-cell regulation by CD28 and CTLA-4
    Alegre, ML
    Frauwirth, KA
    Thompson, CB
    NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) : 220 - 228
  • [34] Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, marine myelogenous leukemia
    LaBelle, JL
    Hanke, CA
    Blazar, BR
    Truitt, RL
    BLOOD, 2002, 99 (06) : 2146 - 2153
  • [35] Induction of T cell anergy in the absence of CTLA-4/B7 interaction
    Frauwirth, KA
    Alegre, ML
    Thompson, CB
    JOURNAL OF IMMUNOLOGY, 2000, 164 (06): : 2987 - 2993
  • [36] A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection
    Buhlmann, JE
    Elkin, SK
    Sharpe, AH
    JOURNAL OF IMMUNOLOGY, 2003, 170 (11): : 5421 - 5428
  • [37] Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2)
    Morton, PA
    Fu, XT
    Stewart, JA
    Giacoletto, KS
    White, SL
    Leysath, CE
    Evans, RJ
    Shieh, JJ
    Karr, RW
    JOURNAL OF IMMUNOLOGY, 1996, 156 (03): : 1047 - 1054
  • [38] Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population
    Anderson, DE
    Bieganowska, KD
    Bar-Or, A
    Oliveira, EML
    Carreno, B
    Collins, M
    Hafler, DA
    NATURE MEDICINE, 2000, 6 (02) : 211 - 214
  • [39] Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population
    David E. Anderson
    Katarzyna D. Bieganowska
    Amit Bar-Or
    Enedina M.L. Oliveira
    Beatriz Carreno
    Mary Collins
    David A. Hafler
    Nature Medicine, 2000, 6 : 211 - 214
  • [40] Regulation of T-cell activation by CD28 and CTLA-4
    Nagel, T
    Kalden, JR
    Manger, B
    MEDIZINISCHE KLINIK, 1998, 93 (10) : 592 - 597